Fri, December 11, 2020
Thu, December 10, 2020
Wed, December 9, 2020
Tue, December 8, 2020
Mon, December 7, 2020
Fri, December 4, 2020
Thu, December 3, 2020
Wed, December 2, 2020
Tue, December 1, 2020
Mon, November 30, 2020
Sun, November 29, 2020
Fri, November 27, 2020
Wed, November 25, 2020
Tue, November 24, 2020

Konstantinos Aprilakis Initiated (BPMC) at Hold and Held Target at $110 on, Dec 3rd, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-110-on-dec-3rd-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Konstantinos Aprilakis of Stifel, Initiated "Blueprint Medicines Corporation" (BPMC) at Hold and Held Target at $110 on, Dec 3rd, 2020.

Konstantinos has made no other calls on BPMC in the last 4 months.



There are 5 other peers that have a rating on BPMC. Out of the 5 peers that are also analyzing BPMC, 2 agree with Konstantinos's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Eun Yang of "Jefferies" Downgraded from Strong Buy to Hold and Held Target at $96 on, Monday, November 2nd, 2020
  • David Lebovitz of "Morgan Stanley" Downgraded from Buy to Hold on, Friday, October 30th, 2020


These are the ratings of the 3 analyists that currently disagree with Konstantinos


  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $120 on, Thursday, October 29th, 2020
  • Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $122 on, Friday, October 16th, 2020
  • Andrew Berens of "Morgan Stanley" Maintained at Buy with Increased Target to $100 on, Tuesday, October 13th, 2020